AVTE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,304,582.48

Aerovate Therapeutics Insider Trading History Chart

Aerovate Therapeutics Share Price & Price History

^$2.53

+0.30 (1.20%)

As of 12/20/2024 06:15 PM ET

Days: 30 | 90 | 365

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.

Aerovate Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2024	George A Eldridge	Insider	Sell	15,000	$25.03	$375,450.00	5,022
5/17/2024	Hunter Gillies	Insider	Sell	4,000	$21.08	$84,320.00	5,602
5/16/2024	Timothy P. Noyes	CEO	Sell	10,000	$21.58	$215,800.00
5/2/2024	Marinus Verwijs	Insider	Sell	1,981	$21.02	$41,640.62
5/1/2024	Timothy P. Noyes	CEO	Sell	11,357	$20.34	$231,001.38
4/17/2024	Benjamin T Dake	Insider	Sell	6,853	$22.37	$153,301.61	1,291
4/16/2024	Timothy P. Noyes	CEO	Sell	10,000	$24.70	$247,000.00
4/10/2024	George A Eldridge	Insider	Sell	7,500	$26.85	$201,375.00	1,960
4/9/2024	David S Grayzel	Director	Sell	11,882	$28.15	$334,478.30	14,502
4/1/2024	Benjamin T Dake	Insider	Sell	3,325	$31.97	$106,300.25	1,291
4/1/2024	Timothy P. Noyes	CEO	Sell	10,000	$30.00	$300,000.00
3/27/2024	Benjamin T Dake	Insider	Sell	11,068	$27.97	$309,571.96	1,291
3/25/2024	Benjamin T Dake	Insider	Sell	3,432	$28.01	$96,130.32	1,291
3/19/2024	Marinus Verwijs	insider	Sell	5,300	$26.08	$138,224.00	1,291
3/13/2024	George A Eldridge	Insider	Sell	2,016	$25.02	$50,440.32	1,960
3/11/2024	George A Eldridge	Insider	Sell	3,433	$25.25	$86,683.25	1,960
3/8/2024	George A Eldridge	Insider	Sell	114	$25.00	$2,850.00	1,960
2/23/2024	Hunter Gillies	Insider	Sell	511	$19.50	$9,964.50	3,251
2/20/2024	Hunter Gillies	Insider	Sell	3,489	$20.23	$70,582.47	3,251
2/5/2024	Ralph Niven	Insider	Sell	4,600	$17.45	$80,270.00	1,609
1/17/2024	Hunter Gillies	Insider	Sell	4,000	$19.50	$78,000.00	3,251
1/5/2024	Ralph Niven	Insider	Sell	4,600	$19.16	$88,136.00	1,609
12/27/2023	Hunter Gillies	Insider	Sell	125	$24.50	$3,062.50	3,251
12/20/2023	Hunter Gillies	Insider	Sell	4,000	$19.50	$78,000.00	3,251
12/13/2023	Hunter Gillies	Insider	Sell	2,103	$19.50	$41,008.50	3,251
12/5/2023	Ralph Niven	Insider	Sell	4,600	$16.30	$74,980.00	1,609
11/27/2023	Benjamin T Dake	Insider	Sell	12,517	$16.24	$203,276.08	1,291
11/24/2023	Benjamin T Dake	Insider	Sell	4,990	$15.74	$78,542.60	1,291
11/22/2023	Benjamin T Dake	Insider	Sell	9,382	$15.17	$142,324.94	1,291
11/1/2023	Marinus Verwijs	CTO	Sell	970	$10.46	$10,146.20
11/1/2023	Timothy P. Noyes	CEO	Sell	1,092	$10.42	$11,378.64
9/6/2023	Benjamin T Dake	Insider	Sell	3,931	$15.06	$59,200.86	1,291
8/7/2023	Benjamin T Dake	Insider	Sell	10,283	$15.52	$159,592.16	1,291
7/28/2023	Timothy P. Noyes	CEO	Sell	5,478	$18.00	$98,604.00
7/17/2023	Timothy P. Noyes	CEO	Sell	4,522	$18.11	$81,893.42
7/6/2023	Benjamin T Dake	Insider	Sell	10,283	$16.66	$171,314.78	1,291
7/3/2023	Timothy P. Noyes	CEO	Sell	10,000	$18.00	$180,000.00
6/5/2023	Ralph Niven	Insider	Sell	2,250	$16.26	$36,585.00	1,609
5/19/2023	Hunter Gillies	Insider	Sell	65	$19.50	$1,267.50	3,251
5/17/2023	Hunter Gillies	Insider	Sell	1,090	$19.59	$21,353.10	3,251
5/8/2023	Benjamin T Dake	Insider	Sell	10,284	$21.80	$224,191.20	1,291
5/5/2023	Ralph Niven	Insider	Sell	2,250	$20.87	$46,957.50	1,609
5/3/2023	Marinus Verwijs	SVP	Sell	759	$20.79	$15,779.61
5/1/2023	Timothy P Noyes	CEO	Sell	15,000	$20.61	$309,150.00	693
4/21/2023	Hunter Gillies	Insider	Sell	4,000	$19.50	$78,000.00	1,960
4/6/2023	Benjamin T. Dake	insider	Sell	10,283	$18.17	$186,842.11	1,609
4/3/2023	Timothy P. Noyes	CEO	Sell	15,000	$19.39	$290,850.00
3/6/2023	Benjamin T. Dake	insider	Sell	10,282	$23.73	$243,991.86	1,609
3/1/2023	Timothy P. Noyes	CEO	Sell	15,000	$23.81	$357,150.00
2/6/2023	Benjamin T. Dake	insider	Sell	10,284	$24.59	$252,883.56	1,609
2/1/2023	Timothy P. Noyes	CEO	Sell	15,000	$22.68	$340,200.00
1/6/2023	Benjamin T. Dake	insider	Sell	10,284	$25.98	$267,178.32	1,609
1/3/2023	Timothy P. Noyes	CEO	Sell	15,000	$27.07	$406,050.00
12/12/2022	George A Eldridge	Insider	Sell	10,000	$30.04	$300,400.00	1,960
12/8/2022	George A Eldridge	Insider	Sell	12,011	$23.87	$286,702.57	1,960
12/5/2022	Ralph Niven	Insider	Sell	2,250	$17.38	$39,105.00	1,609
12/1/2022	Timothy P. Noyes	CEO	Sell	15,000	$18.00	$270,000.00
11/30/2022	George A Eldridge	Insider	Sell	85	$19.06	$1,620.10	1,960
11/23/2022	George A Eldridge	Insider	Sell	1,261	$19.07	$24,047.27	1,960
11/21/2022	George A Eldridge	Insider	Sell	2	$19.00	$38.00	1,960
11/18/2022	George A Eldridge	Insider	Sell	861	$19.52	$16,806.72	1,960
11/11/2022	Benjamin T. Dake	insider	Sell	6,198	$20.69	$128,236.62
11/8/2022	Benjamin T. Dake	insider	Sell	8,373	$18.09	$151,467.57	1,609
11/2/2022	Marinus Verwijs	SVP	Sell	1,130	$18.89	$21,345.70
11/1/2022	Timothy P. Noyes	CEO	Sell	1,038	$19.50	$20,241.00
10/17/2022	Benjamin T. Dake	insider	Sell	4,185	$20.16	$84,369.60
10/14/2022	Benjamin T. Dake	insider	Sell	110	$20.05	$2,205.50
10/10/2022	Benjamin T. Dake	insider	Sell	4,954	$16.89	$83,673.06
10/7/2022	Benjamin T. Dake	insider	Sell	10,520	$16.01	$168,425.20
10/5/2022	Ralph Niven	Insider	Sell	2,250	$15.75	$35,437.50	1,609
9/12/2022	Benjamin T. Dake	insider	Sell	7,520	$17.33	$130,321.60
9/8/2022	Benjamin T. Dake	insider	Sell	3,120	$18.20	$56,784.00
9/6/2022	Benjamin T. Dake	insider	Sell	9,166	$18.53	$169,845.98
8/18/2022	Ralph Niven	Insider	Sell	2,250	$21.18	$47,655.00	1,609
8/16/2022	Benjamin T. Dake	insider	Sell	21,000	$23.00	$483,000.00
8/11/2022	Benjamin T. Dake	insider	Sell	1,347	$23.93	$32,233.71
8/8/2022	Benjamin T. Dake	insider	Sell	6,943	$24.62	$170,936.66

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Aerovate Therapeutics (NASDAQ:AVTE)

Institutional Buying and Selling by Quarter

Aerovate Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	18,972	$39K	0.0%	+310.8%	0.066%
11/16/2024	Geode Capital Management LLC	291,887	$0.61M	0.0%	-8.0%	1.011%
11/15/2024	Barclays PLC	18,972	$39K	0.0%	+310.8%	0.066%
11/15/2024	Jane Street Group LLC	17,805	$37K	0.0%	-86.0%	0.062%
11/15/2024	State Street Corp	367,468	$0.77M	0.0%	+7.7%	1.272%
11/14/2024	Verition Fund Management LLC	99,815	$0.21M	0.0%	-59.9%	0.346%
11/13/2024	FMR LLC	82,919	$0.17M	0.0%	+54,095.4%	0.287%
11/12/2024	Charles Schwab Investment Management Inc.	29,351	$61K	0.0%	-43.7%	0.102%
11/5/2024	GSA Capital Partners LLP	413,795	$0.87M	0.1%	+226.8%	1.433%
9/16/2024	Cubist Systematic Strategies LLC	31,894	$53K	0.0%	N/A	0.111%
8/15/2024	Deerfield Management Company L.P. Series C	1,411,608	$2.34M	0.0%	N/A	4.898%
8/15/2024	Affinity Asset Advisors LLC	200,000	$0.33M	0.0%	N/A	0.694%
8/14/2024	Cubist Systematic Strategies LLC	31,894	$53K	0.0%	N/A	0.111%
8/12/2024	XTX Topco Ltd	21,143	$35K	0.0%	N/A	0.073%
8/9/2024	Atlas Venture Life Science Advisors LLC	1,799,232	$2.99M	0.3%	-11.8%	6.243%
8/9/2024	Warberg Asset Management LLC	67,449	$0.11M	0.0%	N/A	0.234%
8/6/2024	Quest Partners LLC	32,856	$55K	0.0%	+610.2%	0.114%
7/26/2024	Bank of New York Mellon Corp	46,988	$78K	0.0%	+69.9%	0.163%
7/19/2024	Values First Advisors Inc.	15,381	$26K	0.0%	N/A	0.053%
7/12/2024	SG Americas Securities LLC	179,493	$0.30M	0.0%	N/A	0.623%
5/17/2024	Ikarian Capital LLC	367,965	$10.88M	1.2%	N/A	1.277%
5/16/2024	California State Teachers Retirement System	1,124	$33K	0.0%	-38.9%	0.004%
5/14/2024	EntryPoint Capital LLC	3,126	$92K	0.1%	-49.0%	0.011%
5/10/2024	Vanguard Group Inc.	672,275	$19.88M	0.0%	+7.2%	2.410%
2/20/2024	Eventide Asset Management LLC	12,178	$0.28M	0.0%	N/A	0.044%
2/15/2024	Octagon Capital Advisors LP	403,685	$9.14M	1.5%	-18.8%	1.459%
2/15/2024	Parkwood LLC	15,786	$0.36M	0.0%	-23.6%	0.057%
2/15/2024	Great Point Partners LLC	1,037,690	$23.48M	4.0%	-4.9%	3.750%
2/14/2024	Vestal Point Capital LP	400,000	$9.05M	1.0%	N/A	1.446%
11/15/2023	Alps Advisors Inc.	20,395	$0.28M	0.0%	+11.3%	0.074%
11/14/2023	Fred Alger Management LLC	24,747	$0.34M	0.0%	-57.2%	0.090%
11/13/2023	Silverarc Capital Management LLC	100,000	$1.36M	0.4%	N/A	0.362%
11/13/2023	FMR LLC	529,544	$7.19M	0.0%	-27.2%	1.915%
11/8/2023	Swiss National Bank	21,201	$0.29M	0.0%	+30.9%	0.077%
9/21/2023	Barclays PLC	3,406	$58K	0.0%	-27.8%	0.012%
8/15/2023	HighVista Strategies LLC	41,803	$0.72M	0.3%	+164.0%	0.151%
8/14/2023	Great Point Partners LLC	932,158	$15.99M	3.1%	+23.4%	3.377%
8/14/2023	TCG Crossover Management LLC	2,201,274	$37.75M	6.2%	+103.6%	7.976%
8/14/2023	Driehaus Capital Management LLC	1,194,091	$20.48M	0.3%	N/A	4.326%
7/31/2023	Strs Ohio	2,300	$39K	0.0%	N/A	0.008%
6/1/2023	Golden State Equity Partners	10,530	$0.21M	0.1%	N/A	0.042%
5/16/2023	Great Point Partners LLC	755,620	$15.24M	3.0%	+99.6%	3.046%
5/16/2023	Atlas Venture Life Science Advisors LLC	2,039,249	$41.13M	5.6%	+1.1%	8.219%
5/16/2023	Baker BROS. Advisors LP	1,963,479	$39.60M	0.2%	-0.7%	7.914%
5/15/2023	Ghost Tree Capital LLC	200,000	$4.03M	1.2%	+48.1%	0.806%
5/12/2023	Nan Fung Group Holdings Ltd	47,936	$0.97M	0.7%	-5.3%	0.193%
5/11/2023	Skandinaviska Enskilda Banken AB publ	50,866	$1.03M	0.0%	-4.6%	0.205%
3/23/2023	MetLife Investment Management LLC	5,228	$0.15M	0.0%	N/A	0.021%
2/15/2023	Eversept Partners LP	91,252	$2.67M	0.2%	N/A	0.374%
2/15/2023	Atlas Venture Life Science Advisors LLC	2,017,521	$59.11M	7.1%	-13.3%	8.265%
2/15/2023	Nantahala Capital Management LLC	15,700	$0.46M	0.0%	N/A	0.064%
2/14/2023	VR Adviser LLC	747,869	$21.91M	3.5%	-10.3%	3.064%
2/14/2023	Parkwood LLC	20,560	$0.60M	0.1%	-3.7%	0.084%
2/10/2023	Cheyne Capital Management UK LLP	18,927	$0.56M	1.0%	N/A	0.078%
2/8/2023	Skandinaviska Enskilda Banken AB publ	53,340	$1.56M	0.0%	-5.5%	0.219%
2/8/2023	Swiss National Bank	20,701	$0.61M	0.0%	N/A	0.085%
11/15/2022	TCG Crossover Management LLC	959,572	$15.91M	4.8%	+7.9%	3.931%
11/15/2022	Citadel Advisors LLC	1,615,578	$26.79M	0.0%	+1.5%	6.619%
11/14/2022	Lynx1 Capital Management LP	276,447	$4.58M	4.1%	+44.3%	1.133%
11/14/2022	Cormorant Asset Management LP	2,330,691	$38.64M	2.7%	+34.7%	9.548%
11/14/2022	Boothbay Fund Management LLC	35,757	$0.59M	0.0%	N/A	0.146%
11/14/2022	Ergoteles LLC	10,574	$0.18M	0.0%	-41.3%	0.043%
11/14/2022	VR Adviser LLC	833,927	$13.83M	2.0%	+41.2%	3.416%
11/14/2022	Parkwood LLC	21,344	$0.35M	0.1%	-34.2%	0.087%
11/14/2022	Altium Capital Management LP	51,000	$0.85M	0.3%	N/A	0.209%
11/14/2022	Ghost Tree Capital LLC	150,000	$2.49M	0.7%	N/A	0.615%
11/9/2022	Atlas Venture Life Science Advisors LLC	2,327,909	$38.60M	4.3%	-11.8%	9.537%
11/8/2022	New York State Common Retirement Fund	7,686	$0.13M	0.0%	+48.2%	0.031%
8/16/2022	Parkwood LLC	32,414	$32K	0.1%	N/A	0.133%
8/4/2022	Chicago Partners Investment Group LLC	10,163	$0.23M	0.0%	N/A	0.042%
8/3/2022	Atlas Venture Life Science Advisors LLC	2,638,297	$41.24M	6.9%	-15.0%	10.808%
7/29/2022	Russell Investments Group Ltd.	2,056	$32K	0.0%	N/A	0.008%
6/30/2022	Amalgamated Bank	1,462	$27K	0.0%	N/A	0.006%
5/12/2022	Penn Mutual Asset Management LLC	17,458	$0.32M	0.4%	N/A	0.072%
5/11/2022	Skandinaviska Enskilda Banken AB publ	14,108	$0.26M	0.0%	N/A	0.058%
5/10/2022	Sectoral Asset Management Inc.	218,913	$4.01M	0.7%	-22.6%	0.897%
5/5/2022	New York State Common Retirement Fund	12,591	$0.23M	0.0%	+164.0%	0.052%
2/18/2022	TCG Crossover Management LLC	853,330	$10.06M	4.7%	N/A	3.496%
2/14/2022	Citadel Advisors LLC	1,597,479	$18.84M	0.0%	+0.2%	6.544%
2/11/2022	Parkwood LLC	37,156	$0.44M	0.1%	-22.7%	0.152%
2/3/2022	OUP Management Co. LLC	603,762	$7.12M	3.2%	N/A	2.473%
2/2/2022	New York State Common Retirement Fund	4,770	$56K	0.0%	+165.0%	0.020%
11/16/2021	Citadel Advisors LLC	1,594,813	$32.41M	0.0%	-1.2%	6.533%
11/15/2021	Point72 Asset Management L.P.	53,872	$1.13M	0.0%	N/A	0.221%
11/15/2021	Sectoral Asset Management Inc	341,367	$7.16M	0.6%	-31.7%	1.398%
11/12/2021	Geode Capital Management LLC	114,423	$2.40M	0.0%	N/A	0.469%
11/9/2021	BlackRock Inc.	483,018	$10.13M	0.0%	N/A	1.979%
11/4/2021	Deutsche Bank AG	5,794	$0.12M	0.0%	N/A	0.024%
11/2/2021	New York State Common Retirement Fund	1,800	$38K	0.0%	N/A	0.007%
10/22/2021	Strs Ohio	2,300	$48K	0.0%	N/A	0.009%
8/17/2021	Millennium Management LLC	65,043	$1.49M	0.0%	N/A	0.281%
8/17/2021	Citadel Advisors LLC	1,614,998	$35.47M	0.0%	N/A	6.989%
8/16/2021	Squarepoint Ops LLC	9,000	$0.21M	0.0%	N/A	0.039%
8/16/2021	RA Capital Management L.P.	8,263,982	$188.67M	3.0%	N/A	35.762%
8/16/2021	Maven Securities LTD	9,854	$0.23M	0.0%	N/A	0.043%
8/16/2021	Goldman Sachs Group Inc.	104,755	$2.39M	0.0%	N/A	0.453%

Data available starting January 2016

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $2.53

$2.45

$2.64

50 Day Range

MA: $2.52

$2.10

$2.79

52 Week Range

Now: $2.53

$1.25

$32.42

Volume

768,549 shs

Average Volume

578,710 shs

Market Capitalization

$73.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Aerovate Therapeutics?: Aerovate Therapeutics' top insider shareholders include:
David S Grayzel (Director)
Hunter Gillies (Insider)
George A Eldridge (Insider)
Benjamin T Dake (Insider)
Ralph Niven (Insider)
Benjamin T Dake (Insider)
Marinus Verwijs (Insider)
Timothy P Noyes (CEO)
Marinus Verwijs (CTO)
Marinus Verwijs (SVP)
Timothy P Noyes (CEO)
Learn More about top insider investors at Aerovate Therapeutics.
Who are the major institutional investors of Aerovate Therapeutics?: Aerovate Therapeutics' top institutional shareholders include:
GSA Capital Partners LLP — 1.43%
State Street Corp — 1.27%
Geode Capital Management LLC — 1.01%
Verition Fund Management LLC — 0.35%
FMR LLC — 0.29%
Charles Schwab Investment Management Inc. — 0.10%
Learn More about top institutional investors of Aerovate Therapeutics stock.
Which major investors are selling Aerovate Therapeutics stock?: Within the previous quarter, AVTE stock was sold by these institutional investors:
Verition Fund Management LLC
Jane Street Group LLC
Geode Capital Management LLC
Charles Schwab Investment Management Inc.
LMR Partners LLP
During the previous year, company insiders that have sold Aerovate Therapeutics company stock include:
David S Grayzel (Director)
Hunter Gillies (Insider)
George A Eldridge (Insider)
Benjamin T Dake (Insider)
Ralph Niven (Insider)
Benjamin T Dake (Insider)
Marinus Verwijs (Insider)
Learn More investors selling Aerovate Therapeutics stock.
Which major investors are buying Aerovate Therapeutics stock?: During the previous quarter, AVTE stock was acquired by institutional investors including:
GSA Capital Partners LLP
FMR LLC
State Street Corp
Barclays PLC
Barclays PLC